ArticleJournal of clinical pathology2012

HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer.

Carlos Gómez-Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.